ZyVersa Therapeutics Inc (NASDAQ: ZVSA) stock jumped 8.20% on Friday to $0.08 against a previous-day closing price of $0.08. With 2.78 million shares changed hands, the volume of the stock remained lighter than its average volume of 7.01 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.0839 whereas the lowest price it dropped to was $0.0701. The 52-week range on ZVSA shows that it touched its highest point at $25.00 and its lowest point at $0.07 during that stretch. It currently has a 1-year price target of $2.50. Beta for the stock currently stands at 0.42.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ZVSA was up-trending over the past week, with a rise of 23.38%, but this was down by -36.14% over a month. Three-month performance dropped to -49.66% while six-month performance fell -80.63%. The stock lost -99.19% in the past year, while it has lost -94.79% so far this year.

Float and Shares Shorts:

At present, 43.52 million ZVSA shares are outstanding with a float of 39.28 million shares on hand for trading. On Oct 30, 2023, short shares totaled 1.83 million, which was 4.21% higher than short shares on Sep 28, 2023. In addition to Mr. Stephen C. Glover as the firm’s Co-Founder, Chairman, CEO & President, Mr. Peter Wolfe serves as its CFO & Secretary.

Institutional Ownership:

Through their ownership of 27.97% of ZVSA’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 7.36% of ZVSA, in contrast to 3.36% held by mutual funds. Shares owned by individuals account for 0.47%. As the largest shareholder in ZVSA with 4.68% of the stake, L1 Capital Global, Inc. holds 2,034,933 shares worth 2,034,933. A second-largest stockholder of ZVSA, Walleye Capital LLC, holds 980,568 shares, controlling over 2.25% of the firm’s shares. Geode Capital Management LLC is the third largest shareholder in ZVSA, holding 123,130 shares or 0.28% stake. With a 0.27% stake in ZVSA, the Fidelity Extended Market Index Fu is the largest stakeholder. A total of 119,054 shares are owned by the mutual fund manager. The RiverNorth Opportunities Fund Inc, which owns about 0.11% of ZVSA stock, is the second-largest Mutual Fund holder. It holds 48,471 shares valued at 3975.0. Vanguard Extended Market Index Fu holds 0.04% of the stake in ZVSA, owning 17,194 shares worth 1410.0.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ZVSA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ZVSA analysts setting a high price target of $2.50 and a low target of $2.50, the average target price over the next 12 months is $2.50. Based on these targets, ZVSA could surge 3025.0% to reach the target high and rise by 3025.0% to reach the target low. Reaching the average price target will result in a growth of 3025.0% from current levels.

Summary of Insider Activity:

Insiders traded ZVSA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 9 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 3,565,310 while 0 shares were sold.

Leave a Reply

Your email address will not be published. Required fields are marked *